The United States could move a step closer to approving the Pfizer-Biontech Covid vaccine on Thursday, as the Food and Drug Administration’s advisers meet to discuss its authorisation.
But how will Americans get it? Will it be free? And will enough people take it?
BBC global health correspondent Smitha Mundasad explains.
